三甲医院2019年度门诊2型糖尿病合并高尿酸血症患者的用药情况

Situation of Drug Use of Patients with Type 2 Diabetes and Hyperuricemie in the Outpatients in Three A Hospitals in 2019

目的探讨三甲医院2019年度门诊2型糖尿病合并高尿酸血症患者的用药情况。方法根据世界卫生组织年龄段划分标准将入选的2型糖尿病合并高尿酸血症患者分为青年组、中年组及老年组,进行降尿酸和降糖药物用药分析。结果 3组降尿酸合理用药占98%以上,不合理用药占1%~2%,不良反应发生率1%左右,严重的不良反应主要发生在老年组;3组降糖治疗合理用药达95%以上,不合理用药约5%,主要表现在联合用药不合理,不良反应发生率2%左右,严重的不良反应主要集中在中老年组。结论门诊2型糖尿病合并高尿酸血症患者主要集中在中老年男性和老年女性,降糖及降尿酸用药选择较合理,降糖联合用药合理性有待进一步提高。

Objective To investigate the drug use of patients with type 2 diabetes Mellitus(T2 DM) and hyperuricemia in the outpatients in three A hospitals. Methods According to the Age Classification Standard of the WHO, patients with type 2 diabetes and hyperuricemia were divided into a youth group, a middle aged group and an elderly group to do medicinal analysis of reducing uric acid and blood sugar. Results In the three groups, the rational use of reducing uric acid was more than 98%, the irrational use was 1%-2%, the incidence of adverse reaction was about 1%, and the serious adverse reaction mainly occurred in the elderly group. Also, in the three groups, the rational use of antidiabetic drugs was more than 95%, and the irrational use of drugs was about 5%. The main manifestations were the irrational use of combined drugs, the incidence of adverse reactions was about 2%, and the severe adverse reactions were mainly concentrated in the middle-aged and old-aged groups. Conclusion Patients with diabetes and hyperuricemia in the outpatients are mainly middle-aged and elderly women, and the medicine selection of lowering blood sugar and lowering uric acid is reasonable, which needs to be further improved.